Evan C. Lien

Evan C. Lien

Auto-generated profile, based on publicly available information

Evan C. Lien

Department of Metabolism and Nutritional Programming, Van Andel Institute

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Cell
Verified
Journal Article
Closed access
HHHai Hu
Hai Hu
AJAshish Juvekar
Ashish Juvekar
CLCostas Lyssiotis
Costas Lyssiotis
ELEvan C. Lien
Evan C. Lien
JAJohn G. Albeck
John G. Albeck
GWGerburg Wulf
Gerburg Wulf

18 April 2016 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
ELEvan C. Lien
Evan C. Lien
CLCostas Lyssiotis
Costas Lyssiotis
AJAshish Juvekar
Ashish Juvekar
HHHai Hu
Hai Hu
JAJohn M. Asara
John M. Asara
ATAlex Toker
Alex Toker
Lien et al. show that oncogenic PI(3)K/Akt signalling stimulates glutathione (GSH) synthesis by activation of the transcription factor Nrf2 and regulation of GSH biosynthesis genes in breast cancer. Cancer cells often select for mutations that enhance signalling through pathways that promote anabolic metabolism1. Although the PI(3)K/Akt signalling pathway, which is frequently dysregulated in breast cancer2, is a well-established regulator of central glucose metabolism and aerobic glycolysis3,4, its regulation of other metabolic processes required for tumour growth is not well defined. Here we report that in mammary epithelial cells, oncogenic PI(3)K/Akt stimulates glutathione (GSH) biosynthesis by stabilizing and activating NRF2 to upregulate the GSH biosynthetic genes. Increased NRF2 stability is dependent on the Akt-mediated accumulation of p21Cip1/WAF1 and GSK-3β inhibition. Consistently, in human breast tumours, upregulation of NRF2 targets is associated with PI(3)K pathway mutation status and oncogenic Akt activation. Elevated GSH biosynthesis is required for PI(3)K/Akt-driven resistance to oxidative stress, initiation of tumour spheroids, and anchorage-independent growth. Furthermore, inhibition of GSH biosynthesis with buthionine sulfoximine synergizes with cisplatin to selectively induce tumour regression in PI(3)K pathway mutant breast cancer cells, both in vitro and in vivo. Our findings provide insight into GSH biosynthesis as a metabolic vulnerability associated with PI(3)K pathway mutant breast cancers.

18 July 2016 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
ACAndrew G. Cox
Andrew G. Cox
KLKatie N. Lee
Katie N. Lee
KBKristin K. Brown
Kristin K. Brown
KEKimberley J. Evason
Kimberley J. Evason
SBSebastian Beltz
Sebastian Beltz
WGWolfram Goessling
Wolfram Goessling
The Hippo pathway is an important regulator of organ size and tumorigenesis. It is unclear, however, how Hippo signalling provides the cellular building blocks required for rapid growth. Here, we demonstrate that transgenic zebrafish expressing an activated form of the Hippo pathway effector Yap1 (also known as YAP) develop enlarged livers and are prone to liver tumour formation. Transcriptomic and metabolomic profiling identify that Yap1 reprograms glutamine metabolism. Yap1 directly enhances glutamine synthetase (glul) expression and activity, elevating steady-state levels of glutamine and enhancing the relative isotopic enrichment of nitrogen during de novo purine and pyrimidine biosynthesis. Genetic or pharmacological inhibition of GLUL diminishes the isotopic enrichment of nitrogen into nucleotides, suppressing hepatomegaly and the growth of liver cancer cells. Consequently, Yap-driven liver growth is susceptible to nucleotide inhibition. Together, our findings demonstrate that Yap1 integrates the anabolic demands of tissue growth during development and tumorigenesis by reprogramming nitrogen metabolism to stimulate nucleotide biosynthesis.

25 August 2016
Verified
Book Chapter
Closed access
PDF file
ELEvan C. Lien
Evan C. Lien
CLCostas Lyssiotis
Costas Lyssiotis
LCLewis C. Cantley
Lewis C. Cantley

1 December 2014 in Cell Stem Cell
Verified
Journal Article
Closed access
BCBenjamin G. Cuiffo
Benjamin G. Cuiffo
ACAntoine Campagne
Antoine Campagne
GBGeorge W. Bell
George W. Bell
ALAntonio Lembo
Antonio Lembo
FOFrancesca Orso
Francesca Orso
Antoine E. KarnoubAntoine E. Karnoub
Antoine E. Karnoub

17 September 2019 in Nature Reviews Cancer
Verified
Journal Article
Closed access
PDF file
ELEvan C. Lien
Evan C. Lien
MHMatthew G. Vander Heiden
Matthew G. Vander Heiden